Deccan Health Care Limited (BOM:542248)
India · Delayed Price · Currency is INR 12.45
-0.64 (-4.89%)
At close: Aug 17, 2026
Deccan Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 818.53 | 819.05 | 750.58 | 597.29 | 450.22 | 331.71 | |
Revenue Growth | -0.35% | 9.12% | 25.66% | 32.67% | 35.73% | -1.79% |
Cost of Revenue | 500.83 | 503.82 | 475.86 | 375.72 | 250.18 | 144.83 |
Gross Profit | 317.71 | 315.23 | 274.72 | 221.57 | 200.04 | 186.88 |
Selling, General & Admin | 52.09 | 53.38 | 45.42 | 36.24 | 33.79 | 21.95 |
Other Operating Expenses | 213.01 | 210.98 | 197.79 | 147.82 | 146.63 | 107.29 |
Operating Expenses | 279.54 | 278.99 | 257.74 | 198.73 | 194.69 | 143.97 |
Operating Income | 38.17 | 36.23 | 16.99 | 22.84 | 5.35 | 42.91 |
Interest Expense | -5.05 | -3.66 | -0.58 | -0.56 | -0.86 | -1.13 |
Interest & Investment Income | - | - | 0.01 | 0.14 | 0.16 | 0.04 |
Other Non Operating Income (Expenses) | 0.09 | 0.09 | -0.12 | -0.28 | -0.26 | 0.44 |
EBT Excluding Unusual Items | 33.2 | 32.66 | 16.3 | 22.14 | 4.4 | 42.26 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -2.84 |
Other Unusual Items | - | - | - | - | - | -34 |
Pretax Income | 33.2 | 32.66 | 16.3 | 22.14 | 4.4 | 5.43 |
Income Tax Expense | 7.79 | 7.78 | 4.72 | 7.21 | 1.34 | 2.2 |
Net Income | 25.42 | 24.88 | 11.59 | 14.93 | 3.06 | 3.23 |
Net Income to Common | 25.42 | 24.88 | 11.59 | 14.93 | 3.06 | 3.23 |
Net Income Growth | 145.94% | 114.69% | -22.37% | 387.62% | -5.12% | -17.26% |
Shares Outstanding (Basic) | 25 | 25 | 22 | 19 | 13 | 16 |
Shares Outstanding (Diluted) | 25 | 25 | 26 | 19 | 13 | 16 |
Shares Change | -1.74% | -4.35% | 38.37% | 45.91% | -18.83% | - |
EPS (Basic) | 1.03 | 1.01 | 0.54 | 0.80 | 0.24 | 0.21 |
EPS (Diluted) | 1.03 | 1.01 | 0.45 | 0.80 | 0.24 | 0.21 |
EPS Growth | 150.30% | 124.44% | -43.75% | 233.33% | 16.90% | -17.26% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -61.89 | -67.47 | -127.92 | -67.65 | -6.85 |
Free Cash Flow Per Share | - | -2.51 | -2.62 | -6.87 | -5.30 | -0.44 |
Gross Margin | 38.81% | 38.49% | 36.60% | 37.10% | 44.43% | 56.34% |
Operating Margin | 4.66% | 4.42% | 2.26% | 3.82% | 1.19% | 12.93% |
Profit Margin | 3.10% | 3.04% | 1.54% | 2.50% | 0.68% | 0.97% |
Free Cash Flow Margin | - | -7.56% | -8.99% | -21.42% | -15.02% | -2.07% |
EBITDA | 52.83 | 50.87 | 31.51 | 37.51 | 19.62 | 57.63 |
EBITDA Margin | 6.46% | 6.21% | 4.20% | 6.28% | 4.36% | 17.37% |
D&A For EBITDA | 14.66 | 14.64 | 14.53 | 14.67 | 14.28 | 14.73 |
EBIT | 38.17 | 36.23 | 16.99 | 22.84 | 5.35 | 42.91 |
EBIT Margin | 4.66% | 4.42% | 2.26% | 3.82% | 1.19% | 12.93% |
Effective Tax Rate | 23.45% | 23.83% | 28.92% | 32.58% | 30.38% | 40.53% |
Revenue as Reported | 818.62 | 819.14 | 750.64 | 597.44 | 450.41 | 333.92 |